Lygos Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 25

Lygos General Information

Description

Operator of a sustainable specialty chemical company intended to replace persistent and sometimes toxic chemicals with products that are better, cleaner, and cost-effective. The company uses a multi-disciplined, vertically integrated platform that leverages partnerships across the value chain, enabling clients to develop and deliver products that are high-performing and sustainable.

Contact Information

Website
www.lygos.com
Formerly Known As
KFK
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25821 Industrial Boulevard
  • Suite 300
  • Hayward, CA 94545
  • United States
+1 (510)
Primary Industry
Specialty Chemicals
Vertical(s)
Corporate Office
  • 25821 Industrial Boulevard
  • Suite 300
  • Hayward, CA 94545
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lygos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
25. Accelerator/Incubator Completed Generating Revenue
24. Later Stage VC 01-Sep-2025 Completed Generating Revenue
23. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
22. Later Stage VC 27-Oct-2022 Completed Generating Revenue
21. Merger/Acquisition 18-Apr-2022 Cancelled Generating Revenue
20. Debt - PPP 13-Apr-2020 Completed Generating Revenue
19. Grant 03-Jun-2019 Completed Generating Revenue
18. Grant 11-Mar-2019 Completed Generating Revenue
17. Later Stage VC (Series B2) 23-Jan-2019 $15M $49.7M Completed Generating Revenue
16. Grant 31-Dec-2018 $800K $34.7M Completed Generating Revenue
To view Lygos’s complete valuation and funding history, request access »

Lygos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2 13,404,958 $0.001000 $0.73 $0.73 1x $0.73 15.11%
Series A-1 6,648,543 $0.001000 8% $0.18 $0.18 1x $0.18 7.5%
To view Lygos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lygos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a sustainable specialty chemical company intended to replace persistent and sometimes toxic chemicals with p
Specialty Chemicals
Hayward, CA
60 As of 2025

Waltham, MA
 

Emeryville, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lygos Competitors (13)

One of Lygos’s 13 competitors is Manus, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Manus Venture Capital-Backed Waltham, MA
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
Biocatalysts Corporate Backed or Acquired Cardiff, United Kingdom
Mane Corporation Le Bar-sur-Loup, France
Virent Formerly VC-backed Madison, WI
You’re viewing 5 of 13 competitors. Get the full list »

Lygos Patents

Lygos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025101434-A1 Crosslinked superabsorbent polyaspartic acid or a salt thereof Inactive 10-Nov-2023
WO-2024233705-A2 Recombinant host cell for producing aspartate Inactive 08-May-2023
WO-2024233705-A3 Recombinant host cell for producing aspartate Inactive 08-May-2023
WO-2024054828-A2 Recombinant host cells for the production of malonate Inactive 06-Sep-2022
WO-2024054828-A3 Recombinant host cells for the production of malonate Inactive 06-Sep-2022 C12N9/16
To view Lygos’s complete patent history, request access »

Lygos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lygos Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Four Cities Capital Venture Capital Minority
Change Chemistry Accelerator/Incubator
Flexible Solutions International Corporation Minority
Angel (individual) Minority
LG Technology Ventures Corporate Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

Lygos Acquisitions (1)

Lygos’s most recent deal was a Merger/Acquisition with Librede for . The deal was made on 15-Jan-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Librede 15-Jan-2020 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Lygos’s complete acquisitions history, request access »

Lygos FAQs

  • When was Lygos founded?

    Lygos was founded in 2011.

  • Where is Lygos headquartered?

    Lygos is headquartered in Hayward, CA.

  • What is the size of Lygos?

    Lygos has 60 total employees.

  • What industry is Lygos in?

    Lygos’s primary industry is Specialty Chemicals.

  • Is Lygos a private or public company?

    Lygos is a Private company.

  • What is Lygos’s current revenue?

    The current revenue for Lygos is .

  • How much funding has Lygos raised over time?

    Lygos has raised $210M.

  • Who are Lygos’s investors?

    Four Cities Capital, Change Chemistry, Flexible Solutions International, , and LG Technology Ventures are 5 of 25 investors who have invested in Lygos.

  • Who are Lygos’s competitors?

    Manus, Amyris (Biotechnology), Biocatalysts, Mane, and Virent are some of the 13 competitors of Lygos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process